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Abstract
Background Multi-compartment compliance aids (MCAs) are promoted as a potential solution to medicines non-adherence 
despite the absence of high quality evidence of effectiveness of MCA use impacting medicines adherence or any clinical 
outcomes. Furthermore, there is a lack of qualitative research which focuses on the perspectives of older people receiving 
MCAs. Objectives To describe experiences and beliefs surrounding very sheltered housing (VSH) residents’ use of MCAs 
with emphasis on issues of personalisation, reablement, shared decision-making, independence and support. Setting VSH in 
north east Scotland. Methods Qualitative, face-to-face interviews with 20 residents (≥ 65 years, using MCA > 6 months) in 
three VSH complexes. Interviews focused on: when and why the MCA was first introduced; who was involved in making that 
decision; how the MCA was used; perceptions of benefit; and any difficulties encountered. Interviews were audiorecorded, 
transcribed and analysed using a framework approach. Main outcome measure Experiences and beliefs surrounding use 
of MCAs. Results Nine themes were identified: shared decision-making; independence; knowledge and awareness of why 
MCA had been commenced; support in medicines taking; knowledge and awareness of medicines; competent and capable 
to manage medicines; social aspects of carers supporting MCA use; benefits of MCAs; and drawbacks. Conclusion Expe-
riences and beliefs are diverse and highly individual, with themes identified aligning to key strategies and policies of the 
Scottish Government, and other developed countries around the world, specifically personalisation shared decision making, 
independence, reablement and support.
Keywords Ageing · Behavioural medicine · Geriatrics · Patient adherence · Patient education · Primary care · Scotland
Impacts on practice
• Given that the experiences and beliefs surrounding the 
use of MCAs by elderly are diverse and highly individ-
ual, focus should be placed on a person centred approach 
to care.
• Health and social care professionals involved in aspects 
of the supply of MCAs should consider issues of person-
alisation, shared decision-making, independence, reable-
ment and support.
• Issues like peronalisation, independence and reablement 
relate to autonomy, competence, and relatedness which 
are central to Self Determination Theory. Hence this 
theory may provide a framework to support appropriate 
use of MCAs.
Introduction
The World Health Organization (WHO) World Report on 
Ageing and Health highlights that globally, the number and 
proportion of older people is increasing markedly [1]. In 
Scotland, the number of people 65 years and over is esti-
mated to increase by 53% between 2014 and 2039 [2]. In 
2009, the Scottish Government Ministerial Strategic Group 
for Health and Wellbeing developed a strategy, Reshap-
ing Care for Older People, with the goal to ‘optimise the 
independence and wellbeing of older people at home or in 
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a homely setting’ [3]. The strategy places much emphasis 
on a health and social care shift towards ‘personalisation’, 
whereby people become more involved in how services are 
designed and receive the support that is most suited to them. 
More recently, the focus for the support of older people has 
been based on ‘reablement’, to assist older people to learn 
or relearn those skills needed for a successful and fulfilling 
life [4].
Personalisation, reablement, shared decision-making, 
independence and support may be viewed in the context 
of Self Determination Theory (SDT), a theory of motiva-
tion and human behaviour [5]. SDT outlines three key con-
structs which are considered intrinsic psychological needs 
and which contribute to enhanced wellbeing: competence, 
autonomy, and relatedness. Autonomy refers to a need to feel 
volitional and responsible for the execution of a behaviour; 
competence concerns the need for individuals to feel effec-
tive in interactions with their environment; and relatedness, 
the need to feel a sense of belongingness and connectedness 
with others. The theory further highlights the importance 
of the role of the social environment in fostering the three 
psychological needs [6, 7].
These principles of personalisation, reablement, shared 
decision-making, independence and support are of direct 
relevance to the use of medicines in older people [8, 9], 
particularly given the extent of medicines use in this pop-
ulation. Multimorbidity, defined as ‘the co-occurrence of 
two or more chronic medical conditions in one person’, is 
highly prevalent in older people, increasing rapidly with age 
in terms of both prevalence and the number of morbidities 
[10]. Increases in multimorbidity in older people are mir-
rored by the increasing numbers of prescribed medicines, as 
evidenced from data published in the United Kingdom (UK) 
[11, 12], United States [13], and Europe [14].
Medicines non-adherence is one potential consequence of 
the increasing medicines burden in multimorbid older people 
[15, 16], with data suggesting that between 50 and 80% of 
those with chronic conditions may be non-adherent [17]. 
A number of interventions have been proposed as poten-
tial solutions to non-adherence in older people [18, 19]. 
Multi-compartment compliance aids (MCAs), also referred 
to as Monitored Dosage Systems and Dose Administration 
Aids, are repackaging systems for solid dosage form medi-
cines, such as tablets and capsules, where the medicines 
are removed from manufacturer’s original packaging and 
repackaged into the MCA [20]. While these are promoted as 
a potential solution to non-adherence, the Royal Pharmaceu-
tical Society has expressed concern that pharmacy supplied 
MCAs have ‘become regarded as a panacea for medicines 
use and often integrated into practice and service policy 
without giving due consideration to the alternatives’ [20].
Systematic reviews published in 2011 and in 2016 
highlighted the lack of evidence of effectiveness of MCA 
use impacting medicines adherence or any of the clinical 
outcomes studied [21, 22]. In addition, MCA use in older 
people may be linked to reduced medicines related knowl-
edge, thought to be due to not recognising the different 
medicines within the MCA [23]. To date there is a dearth 
of research which has focused on the perspectives of older 
people receiving MCAs. One study of older people living 
independently and an unrelated sample of health profession-
als involved in MCA provision identified mixed views on 
whether MCAs helped or hindered in maintaining independ-
ence and control over medicines [24].
Given the predictions of increased numbers of older peo-
ple globally, the extent of medicines use, the potential for 
non-adherence and consequent MCA use, there is a need 
to ensure that older people are involved in any decision to 
commence an MCA. Ideally that decision should also be 
centred on the principles of personalisation, reablement, 
shared decision-making and independence.
We recently reported a case study of older people pro-
vided with MCAs, their carers and health professionals, the 
aim of which was to explore the factors influencing MCA 
use [25]. Goals of use related to promoting adherence and 
safety, with less emphasis on independence. Beliefs of con-
sequences related to these goals were considered of value, 
with additional consequences of concern around reduced 
awareness of medicines and complexities of changing medi-
cines. In this paper, we focus on the perspectives of the older 
people studied.
Aim of the study
The aim was to describe the experiences and beliefs of 
older people surrounding the use of MCAs, with emphasis 
on issues of personalisation, reablement, shared decision-
making, independence and support.
Ethics approval
This study was approved by the National Health Service 
(NHS) North of Scotland Research Ethical Review Service 
(14/NW/1168) and NHS Grampian Research and Develop-
ment Committee (2014RG002).
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Method
Design
This was a qualitative study comprising individual face-to-
face interviews conducted by a researcher with extensive 
experience in qualitative interviewing.
Setting
The study was conducted within ‘very sheltered housing’ 
(VSH) complexes in the north east of Scotland. In the UK, 
‘sheltered housing’ describes rented housing for older and/
or disabled or other vulnerable people, usually in grouped 
developments. VSH generally has all the features of shel-
tered housing, but has enhanced care and support through 
the service of extra wardens, full-time carers, assistance 
with everyday living, including assistance with medica-
tion, and provision of meals.
Inclusion and exclusion criteria
Residents of three VSH complexes were included if they 
were aged 65 years or over and had been using an MCA for 
6 months or more. Potential participants were identified by 
the VSH senior carer, who excluded those known to have 
significant cognitive or welfare issues.
Recruitment
The National Health Service employed primary care lead 
pharmacist for the area (known to the VSH senior carer) 
met each screened resident, inviting participation. If the 
resident was in agreement, signed, informed consent was 
obtained and a convenient date, time and location for the 
interview arranged.
Interview schedule
Questions in the semi-structured interview schedule 
focused on: when and why the MCA was first introduced; 
who was involved in making that decision; how the MCA 
was used; perceptions of benefit; and any difficulties 
encountered. The interview schedule was reviewed inde-
pendently, for credibility, by four individuals with exper-
tise in health services research. This was followed by pilot-
ing with two participants fulfilling the eligibility criteria 
who were then excluded from the main study.
Data generation
Interviews of approximately 30 min duration took place 
during September to November 2014. Each interview was 
audio-recorded, with permission, transcribed verbatim 
and checked for transcribing accuracy by a member of the 
research team. Recruitment and data generation continued 
to the point of saturation when no further themes were 
emerging from three consecutive interviews.
Data analysis
Members of the research team met to agree consistency of 
the initial coding framework. Data were analysed using the 
Framework Approach of: data familiarisation (e.g. reading 
of transcripts); identifying constructs (e.g. coding relevant 
statements); indexing and charting (e.g. refining codes and 
identifying themes and sub-themes); mapping (e.g. refining 
themes and sub-themes); and interpreting (e.g. interpretation 
of broader picture of themes and sub-themes). Transcripts 
were coded independently by two researchers. Whilst SDT 
was used when interpreting the results, it was not used when 
planning the study and conducting the interviews.
Results
Demographics
Twenty residents across three VSH sites (A, B and C) par-
ticipated; the majority (n = 15) were female, there were no 
refusals. It was perceived that data saturation, whereby no 
new themes emerged, occurred after interviewing twenty 
residents. All were aged 65 years and over, had been using 
an MCA for a minimum of 6 months, and the VSH sen-
ior carer had screened residents to avoid those known to 
have cognitive impairment or welfare issues. Table 1 gives 
the nine key themes and corresponding sub-themes identi-
fied relating to residents experiences of and beliefs around 
using MCAs. There were often contradictory experiences 
and beliefs within the themes.
Shared decision‑making
Although some residents felt that they had been involved in 
the decision to start an MCA, most reported that they could 
not recall if they had been involved, or that they had limited 
or no involvement in the decision,
No, I don’t know how it came about at all, you know? 
(Case 5 at C).
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Table 1  Themes and sub-themes
Theme Sub-theme Illustrative quote
Shared decision-making Involved in decision to start MCA Interviewer “So when you say ‘we thought’, 
were you involved in the decision?”
Interviewee “Yes” Case 5 at D
Not involved in decision to start MCA “No, I don’t know how it came about at all, you 
know?’’ Case 5 at C
Cannot recall if involved in decision to start 
MCA
“Now that’s so long ago, I don’t know” Case 3 
at D
Independence Lack of confidence “[carers] Canny [cannot] trust me” Case 1 at D
Loss of independence “That’s what’s getting me down. I canna [can-
not] do the things I used to do” Case 2 at D
No loss of independence “No, no [feel as though independence is going]. 
I’m used to it now” Case 2 at K
Trust in carer “I rely on the carers” Case 4 at K
Knowledge and awareness of why MCA com-
menced
Aware of purpose of MCA “Well, it’s for, it’s for segregating your medica-
tion and letting you know what’s what in it” 
Case 5 at C
Unaware of why MCA started “I think they just said this is how it’s going to 
be and that’s it” Case 3 at D
Knowledge and awareness of medicines Awareness of what medicines are prescribed 
for
“But I mean I know exactly what the tablets are 
for or how many I need” Case 9 at D
Awareness of what some medicines are 
prescribed for
“No, I can differentiate with most of them. The 
ones I can’t is the ones that are all white” 
Case 3 at D
Unaware of what medicines are prescribed for “Furosemide was that ein [one]. Da ken [I don’t 
know] what it’s for” Case 4 at K
Cannot recognise all medicines “No, no I dinna ken [don’t know] them all’’ 
Case 2 at D
Recognises medicines “Well there was one occasion when they were 
giving me tablets and I says ‘oh there’s some-
thing missing here, I’m short’, and it was, 
these white paracetamol” Case 5 at C
Awareness of when to take medicines “Well, actually I’m awful good at phoning. So if 
she’s [carer] not here by half past 5 she’s kens 
[knows] there’ll be a ‘phone call” Case 3 at C
Support in medicines taking Involvement with taking medicines “That’s your responsibility, we’ve given you it, 
if you don’t want to take it just now and you’re 
going to take it later that’s your responsibility, 
you can say yes or no if you want to take it 
and I says well” Case 1 at K
Reduced involvement with taking medicines “No, I never touch them [medicines]” Case 4 
at K
Competent and capable to manage medicines Feels capable/confident “I’m lucky I haven’t got anything wrong with 
my mind, I’m spot on and of course it’s like 
everything else, I’m fine for my memory” 
Case 3 at C
Forgets medicines “But sometimes now I think I’m glad I gave 
them over because sometimes I think I might 
forget them” Case 5 at D
Illness/dexterity “I canna [cannot] see, that’s why I need” Case 
9 at D
Managing meds by self “My inhalers, I order them myself” Case 5 at D
Issues with medicines prior to MCA “Well, when you’re taking them out of a bottle, 
you know, you let it fall and sometimes you 
canna [cannot] find, it” Case 1 at C
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One resident highlighted the involvement of others in the 
decision,
My brother was speaking about it and he says ‘you’d 
be better getting that’. And I says ‘I’ll leave it, one of 
the lassies’ll [carers will] tell me’ and it was (name), 
it was (name) that said that I’d be better. (Case 6 at C)
Independence
Some described a perceived loss of independence as a con-
sequence of not being involved in the administration of their 
medicines, with one expressing frustration over the lack of 
control. Others, however, noted that they did not feel that 
they had lost any independence by not being in control of 
their medicines. One was of the view that having the MCA 
had promoted independence,
I prefer the blister pack, because I mean your dosage 
is done, it’s taken care of and from time to time, if you 
want or if you feel capable, you can open it and you 
look and you see, oh yes, that’s right. (Case 1 at A)
Knowledge and awareness of why MCA commenced
A number of residents recounted their understanding 
of the purpose of the MCA, that it was required due to 
reduced capabilities attributable to loss of dexterity, illness 
and issues with remembering to take medicines. Whilst 
some residents were aware of why and when they had been 
provided with an MCA, others were unable to recall when 
and why it had been started,
Not really. I suppose in case you forgot [medicines]. 
I don’t know, to take them. (Case 1 at B)
Table 1  (continued)
Theme Sub-theme Illustrative quote
Social aspects of carers supporting MCA use Social aspect of MCA “Aye [yes], but when [name] came up and said 
‘I think it [having the MCA] would be better’. 
So I said ‘fair enough’ because when they 
start that it means a girly [carer] to come up” 
Case 6 at D
Benefits of MCAs Ease of using MCA “Well we found them easier to open, they’re all 
together in the one bit and you open them” 
Case 2 at K
Safety of MCA “Well for one thing the medical bottles, as 
you know, very similar and when you’re in a 
hurry, which most of them are, it’s an accident 
waiting to happen” Case 1 at K
MCA alleviates worry about taking medicines “The one good thing about it is the blister pack 
starts on a Monday but they’re delivered on 
a Wednesday. Now, to me that’s a good thing 
because I’m always worried come Saturday or 
Sunday, where’s my tablets” Case 4 at D
MCA promotes control over medicines “Well, it’s for my medicine, my tablets and I 
think it’s a lot better than bottles and that, 
cause you’re not losing them” Case 4 at C
MCA increases confidence Interviewee: “It tells you you’re supposed to 
take…you canna [cannot] miss any [medi-
cines], they’re all there…”
Interviewee: “It gives you confidence”
Interviewee: “Aye, you ken [know] it’s [the 
medicine] there” Case 4 at K
Drawbacks of MCAs Issues with using MCA “I’ve lost a few little ones, dropped on the floor, 
like that thyroid tablets, their tiny” Case 4 at 
K
Complexities of MCA “…and paracetamol, they’re not in the blister 
pack, they’re just loose and they give them as 
well” Case 2 at D
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Knowledge and awareness of medicines
Residents varied in their knowledge and awareness of 
their medicines, with some having high levels of aware-
ness, knowing what medicines were prescribed for and 
how much to take. Others, however, reported that with 
the MCA they had difficulty recognising their medicines,
No, no, I just, well I don’t know if I get anything for 
it, there’s a lot of tablets I don’t know what they’re 
for. (Case 2 at C)
Support in medicines taking
There was diversity over the extent to which residents were 
actively or passively involved in medicines taking. Some 
discussed that they delayed taking their medicines or chose 
to take them at certain times, demonstrating ownership and 
empowerment. For most, their carers prompted or sup-
ported medicines taking from the MCA,
They, they do everything, I don’t have a blister pack 
in my hand at all. (Case 7 at C)
Competent and capable to manage medicines
Several residents reported that they were confident that 
they were competent to manage their medicines. Others 
reported that they were responsible for taking and manag-
ing medicines that were not stored in the MCA. As one 
resident stated,
…because they don’t realise, I mean I’m 79 year old 
now, I know what I’m doing, it’s life, I’ve still got 
my brain up here (Case 6 at B)
Social aspects of carers supporting MCA use
The social aspects of having carers support medicines 
administration from MCAs were highlighted where the 
benefit of having company was described,
But it’s as much because you get the company of 
somebody coming in four times a day. It’s good for 
somebody to come. You’re speaking for a wee while. 
(Case 6 at B)
Benefits of MCAs
MCAs were perceived positively, with residents describing 
associated benefits, for both carers and themselves, includ-
ing increasing medicines adherence, enhanced safety and 
prevention of lost medicines,
Well they make certain that people who might not 
have full comprehension doesn’t take their tablets 
at the wrong time and in the wrong sequence (Case 
3 at C)
Drawbacks of MCAs
Whilst a number of residents reported no disadvantages 
to MCAs, the complexities of MCAs were highlighted by 
several residents, who reported that some medicines were 
not in their MCA. It was also highlighted by some resi-
dents that carers often experienced difficulties in opening 
and using MCAs,
The lassies [carers], the lassies sometimes have a job 
themselves. (Case 6 at B)
Discussion
This study has provided an in-depth description of the per-
spectives of residents of VSH surrounding their experiences 
and beliefs of using MCAs. Nine key themes were identi-
fied: shared decision-making; independence; knowledge and 
awareness of why the MCA had been commenced; support 
in medicines taking; knowledge and awareness of medicines; 
competent and capable to manage medicines; social aspects 
of carers supporting MCA use; benefits of MCAs; and draw-
backs of MCAs. There were many examples of diverse, and 
often polarised, experiences and beliefs within each theme.
Interpretation
Personalisation, shared decision-making, independence, rea-
blement and support are key aims of strategies and policies 
of the Scottish Government [3, 4, 9] and other developed 
countries around the world [26]. Many of the themes of 
experiences and beliefs which emerged in this study align to 
these elements. Shared decision-making and personalisation 
were apparent in those reporting involvement in the decision 
to commence an MCA. This was interpreted as an indica-
tion that involvement in medicines taking was facilitated 
through MCA use in those who were competent and capa-
ble. Similarly, some residents felt that their independence 
was promoted through MCA use and many recounted many 
areas of support derived from MCA use including directly 
in medicines taking, feelings of empowerment and the carers 
aiding medicines administration. There were also aspects of 
reablement, the relearning of skills, in terms of the use of 
MCAs making medicines taking more manageable particu-
larly on occasions where there were issues with memory, 
dexterity, eyesight, stress and being overwhelmed. Residents 
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also described their awareness of their medicines and being 
able to check that the medicines in the MCA were correct, 
given at the appropriate time and in the prescribed amount. 
However, as noted earlier, there were examples of polarised 
experiences and beliefs within the themes with a lack of 
shared decision-making, personalisation and empowerment, 
and general feelings that independence was reduced through 
MCA use. These are important considerations for all health 
and social care professionals involved in the use of MCAs. 
These findings are of particular importance for pharmacists 
and pharmacy staff given their acknowledged roles in the 
provision and review of MCAs in older people [27]. It may 
be beneficial for pharmacists and pharmacy staff to explore 
patient issues around MCA us in an effort to promote shared 
decision-making.
The issue of non-adherence in those with chronic condi-
tions is widely acknowledged [15]. Given the predictions 
of the increasingly older population, combined with preva-
lence of multimorbidity and numbers of prescribed medi-
cines, there is potential for these non-adherence statistics to 
increase. MCAs represent one potential solution for those 
whose non-adherence is non-intentional and indeed promot-
ing adherence was noted as a benefit in this study and others 
[24, 25]. While systematic reviews have failed to demon-
strate objectively that MCAs improve adherence [21, 22], 
there are particular issues around obtaining valid and reli-
able measures of adherence in those receiving MCAs. The 
perspectives of the individual and their attendant carers and 
health professionals should therefore not be underestimated. 
There is a need to ensure, however, that MCAs are targeted 
to the correct individuals, and there is strong evidence of the 
need for review of all medicines [28–31].
It is clear from the findings of this study that the experi-
ences and beliefs around MCA use in older people are very 
individual and hence diverse. The elements of personali-
sation, shared decision-making, independence, reablement 
and support may all relate to, and be interpreted, by SDT. 
The themes ‘knowledge and awareness of why MCA com-
menced’, ‘support in medicines taking’ and ‘independence’ 
may all be encapsulated within the SDT need for autonomy. 
Specifically, in relation to MCAs, residents demonstrated 
varying levels of autonomy in relation to management of 
their medicines with some reporting a high degree of respon-
sibility and others, limited involvement in the process. The 
themes ‘knowledge and awareness of medicines’, ‘competent 
and capable to manage medicines’ may pertain to the com-
petence need of SDT. Residents often demonstrated a desire 
to manage their own medicines since they felt capable of 
doing so, however, conversely, others were relatively happy 
to absolve responsibility of managing their medicines since 
they believed they were less capable. The ‘social aspects of 
carers supporting MCA use’ may relate to the relatedness 
need outlined in SDT. Residents discussed the role of the 
carer in managing medicines and how this was considered 
to be a more social aspect of having an MCA.
Perhaps, prior to initiation of an MCA, it may prove 
beneficial for health and social care professionals to con-
sider the individual needs of residents in relation to using 
MCAs within the context of SDT. Performing tailored theo-
retical analyses of residents’ psychological needs may aid 
personalised goal setting and plans for monitoring MCA 
use thereafter. The tenet of personalisation may be particu-
larly important moving forward. Custer et al. in a study of 
need fulfilment in nursing home residents using SDT as a 
foundation, highlighted the individuality and variability in 
how residents perceived the importance of autonomy and 
competence. Although being provided with the opportunity 
to make decisions and complete tasks independently were 
critical factors in ensuring fulfilment of needs for some, they 
were not priorities for others [32].
Strengths and weaknesses
There are several strengths to this study which are based 
around the measures to promote credibility (e.g. adopting 
research methods well established in qualitative investiga-
tion, expert review of the interview schedule, iterative ques-
tioning, encouraging residents to be frank in their responses), 
dependability (e.g. an experienced qualitative interviewer) 
and transferability (e.g. detailed description of setting and 
participants). It is also highly likely that the sample size was 
sufficient for saturation of themes and issues. There is also 
a lack of qualitative research in this field hence the findings 
contribute to this limited evidence base. In particular, the 
emphasis on the residents’ perspectives of experiences and 
beliefs complement our overall case study based approach 
which sought to elucidate behavioural determinants of MCA 
use [25]. The study adds to existing literature on MCAs in 
that it has contributed to enhanced understanding of MCA 
use in older adults. There are, however, study limitations 
most notably the issue of transferability of the findings to 
older people resident in other settings and countries with dif-
ferent health and social care systems. Whilst the results were 
viewed through SDT, the theory did not inform the design of 
the study and hence, greater depth may have been attained 
around the three tenets of theory had it been. Furthermore, 
the findings may be impacted by recall bias, particularly 
around issues of reasons for commencing MCAs which may 
have occurred in the distant past.
Further research
Further research should now focus on exploring SDT within 
the context of MCA use in older people. Personalisation 
should be a key consideration since it would assist in ensur-
ing that an individual’s priorities, in terms of psychological 
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needs, correspond with the support that is provided in rela-
tion to management of medicines. Hence, wellbeing may be 
optimised within the population by maintaining congruence 
with regard to both preferences for managing medicines and 
experience.
Conclusion
The experiences and beliefs around MCA use in older peo-
ple are diverse and highly individual. The themes identi-
fied aligned with key strategies and policies of the Scottish 
Government, specifically personalisation shared decision-
making, independence, reablement and support.
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